1 - 25 of 35 results for author:"Heine R." in Literature citations
Results Customize
› Repeat search in UniProtKB (4)
| Glucocorticoid receptor gene polymorphisms are associated with reduced first-phase glucose-stimulated insulin secretion and disposition index in women, but not in men. van Raalte D.H., van Leeuwen N., Simonis-Bik A.M., Nijpels G., van Haeften T.W., Schafer S.A., Boomsma D.I., Kramer M.H., J Heine R., Maassen J.A. et al. Diabet. Med. 29:e211-6(2012) · Mapped (12) |
| beta-Arrestin mediates oxytocin receptor signaling, which regulates uterine contractility and cellular migration. Grotegut C.A., Feng L., Mao L., Heine R.P., Murtha A.P., Rockman H.A. Am. J. Physiol. Endocrinol. Metab. 300:E468-77(2011) · Mapped (16) |
| The impact of genetic variation in the G6PC2 gene on insulin secretion depends on glycemia. Heni M., Ketterer C., Hart L.M., Ranta F., van Haeften T.W., Eekhoff E.M., Dekker J.M., Boomsma D.I., Nijpels G., Kramer M.H. et al. J. Clin. Endocrinol. Metab. 95:E479-84(2010) · Mapped (2) |
| HbA1c is an independent predictor of non-fatal cardiovascular disease in a Caucasian population without diabetes: a 10-year follow-up of the Hoorn Study. van 't Riet E., Rijkelijkhuizen J.M., Alssema M., Nijpels G., Stehouwer C.D., Heine R.J., Dekker J.M. Eur J Prev Cardiol 19:23-31(2012) · Mapped (14) |
| RILLKKMPSV influences the vasculature, neurons and glia, and (pro)renin receptor expression in the retina. Wilkinson-Berka J.L., Heine R., Tan G., Cooper M.E., Hatzopoulos K.M., Fletcher E.L., Binger K.J., Campbell D.J., Miller A.G. Hypertension 55:1454-1460(2010) · Mapped (1) |
| The association between the -374T/A polymorphism of the receptor for advanced glycation endproducts gene and blood pressure and arterial stiffness is modified by glucose metabolism status: the Hoorn and CoDAM studies. Engelen L., Ferreira I., Gaens K.H., Henry R.M., Dekker J.M., Nijpels G., Heine R.J., 't Hart L.M., van Greevenbroek M.M., van der Kallen C.J. et al. J. Hypertens. 28:285-293(2010) · Mapped (36) |
| Association of polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating RAGE levels. Gaens K.H., Ferreira I., van der Kallen C.J., van Greevenbroek M.M., Blaak E.E., Feskens E.J., Dekker J.M., Nijpels G., Heine R.J., 't Hart L.M. et al. J. Clin. Endocrinol. Metab. 94:5174-5180(2009) · Mapped (36) |
| Gene variants in the novel type 2 diabetes loci CDC123/CAMK1D, THADA, ADAMTS9, BCL11A, and MTNR1B affect different aspects of pancreatic beta-cell function. Simonis-Bik A.M., Nijpels G., van Haeften T.W., Houwing-Duistermaat J.J., Boomsma D.I., Reiling E., van Hove E.C., Diamant M., Kramer M.H., Heine R.J. et al. Diabetes 59:293-301(2010) · Mapped (32) |
| Combined risk allele score of eight type 2 diabetes genes is associated with reduced first-phase glucose-stimulated insulin secretion during hyperglycemic clamps. 't Hart L.M., Simonis-Bik A.M., Nijpels G., van Haeften T.W., Schafer S.A., Houwing-Duistermaat J.J., Boomsma D.I., Groenewoud M.J., Reiling E., van Hove E.C. et al. Diabetes 59:287-292(2010) · Mapped (61) |
| Polymorphisms in glyoxalase 1 gene are not associated with vascular complications: the Hoorn and CoDAM studies. Engelen L., Ferreira I., Brouwers O., Henry R.M., Dekker J.M., Nijpels G., Heine R.J., van Greevenbroek M.M., van der Kallen C.J., Blaak E.E. et al. J. Hypertens. 27:1399-1403(2009) · Mapped (1) |
| Genetic association analysis of 13 nuclear-encoded mitochondrial candidate genes with type II diabetes mellitus: the DAMAGE study. Reiling E., van Vliet-Ostaptchouk J.V., van 't Riet E., van Haeften T.W., Arp P.A., Hansen T., Kremer D., Groenewoud M.J., van Hove E.C., Romijn J.A. et al. Eur. J. Hum. Genet. 17:1056-1062(2009) · Mapped (40) |
| Relationship of adiposity with arterial stiffness as mediated by adiponectin in older men and women: the Hoorn Study. Snijder M.B., Flyvbjerg A., Stehouwer C.D., Frystyk J., Henry R.M., Seidell J.C., Heine R.J., Dekker J.M. Eur. J. Endocrinol. 160:387-395(2009) · Mapped (3) |
| A pharmacokinetic and pharmacogenetic study of efavirenz in children: dosing guidelines can result in subtherapeutic concentrations. ter Heine R., Scherpbier H.J., Crommentuyn K.M., Bekker V., Beijnen J.H., Kuijpers T.W., Huitema A.D. Antivir. Ther. (Lond.) 13:779-787(2008) · Mapped (5) |
| Variants of CDKAL1 and IGF2BP2 affect first-phase insulin secretion during hyperglycaemic clamps. Groenewoud M.J., Dekker J.M., Fritsche A., Reiling E., Nijpels G., Heine R.J., Maassen J.A., Machicao F., Schafer S.A., Haring H.U. et al. Diabetologia 51:1659-1663(2008) · Mapped (17) |
| Neuropeptide Y polymorphism significantly magnifies diabetes and cardiovascular disease risk in obesity: the Hoorn Study. Jaakkola U., Kallio J., Heine R.J., Nijpels G., T' Hart L.M., Maassen J.A., Bouter L.M., Stehouwer C.D., Dekker J.M. Eur J Clin Nutr 63:150-152(2009) · Mapped (2) |
| Association of maternal IL-1 receptor antagonist intron 2 gene polymorphism and preterm birth. Murtha A.P., Nieves A., Hauser E.R., Swamy G.K., Yonish B.A., Sinclair T.R., Heine R.P. Am. J. Obstet. Gynecol. 195:1249-1253(2006) · Mapped (2) |
| Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women: the hoorn study. Snijder M.B., Heine R.J., Seidell J.C., Bouter L.M., Stehouwer C.D., Nijpels G., Funahashi T., Matsuzawa Y., Shimomura I., Dekker J.M. Diabetes Care 29:2498-2503(2006) · Mapped (3) |
| The HADHSC gene encoding short-chain L-3-hydroxyacyl-CoA dehydrogenase (SCHAD) and type 2 diabetes susceptibility: the DAMAGE study. van Hove E.C., Hansen T., Dekker J.M., Reiling E., Nijpels G., Jorgensen T., Borch-Johnsen K., Hamid Y.H., Heine R.J., Pedersen O. et al. Diabetes 55:3193-3196(2006) · Mapped (3) |
| Evidence that the mitochondrial leucyl tRNA synthetase (LARS2) gene represents a novel type 2 diabetes susceptibility gene. 't Hart L.M., Hansen T., Rietveld I., Dekker J.M., Nijpels G., Janssen G.M., Arp P.A., Uitterlinden A.G., Jorgensen T., Borch-Johnsen K. et al. Diabetes 54:1892-1895(2005) · Mapped (2) |
| Interactions of dietary fat intake and the hepatic lipase -480C-->T polymorphism in determining hepatic lipase activity: the Hoorn Study. Bos G., Dekker J.M., Feskens E.J., Ocke M.C., Nijpels G., Stehouwer C.D., Bouter L.M., Heine R.J., Jansen H. Am. J. Clin. Nutr. 81:911-915(2005) · Mapped (4) |
| The Gly482Ser variant in the peroxisome proliferator-activated receptor gamma coactivator-1 is not associated with diabetes-related traits in non-diabetic German and Dutch populations. Stumvoll M., Fritsche A., t'Hart L.M., Machann J., Thamer C., Tschritter O., Van Haeften T.W., Jacob S., Dekker J.M., Maassen J.A. et al. Exp. Clin. Endocrinol. Diabetes 112:253-257(2004) · Mapped (10) |
| The relationship of lipoprotein lipase activity and LDL size is dependent on glucose metabolism in an elderly population: the Hoorn Study. Bos G., Scheffer P.G., Vieira D., Dekker J.M., Nijpels G., Diamant M., Teerlink T., Stehouwer C.D., Bouter L.M., Heine R.J. et al. Diabetes Care 27:796-798(2004) · Mapped (9) |
| Genetic factors and insulin secretion: gene variants in the IGF genes. 't Hart L.M., Fritsche A., Rietveld I., Dekker J.M., Nijpels G., Machicao F., Stumvoll M., van Duijn C.M., Haring H.U., Heine R.J. et al. Diabetes 53 Suppl 1:S26-30(2004) · Mapped (10) |
| Lack of association between gene variants in the ALMS1 gene and Type 2 diabetes mellitus. 't Hart L.M., Maassen J.A., Dekker J.M., Heine R.J., Maassen J.A. Diabetologia 46:1023-1024(2003) · Mapped (3) |
| Variations in insulin secretion in carriers of the E23K variant in the KIR6.2 subunit of the ATP-sensitive K(+) channel in the beta-cell. 't Hart L.M., van Haeften T.W., Dekker J.M., Bot M., Heine R.J., Maassen J.A. Diabetes 51:3135-3138(2002) · Mapped (3) |